Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers

• Published in: Annals of clinical and translational neurology 2022-02, Vol.9 (2), p.155-170
• Main Authors: Berger, Miles, Browndyke, Jeffrey N., Cooter Wright, Mary, Nobuhara, Chloe, Reese, Melody, Acker, Leah, Bullock, W. Michael, Colin, Brian J., Devinney, Michael J., Moretti, Eugene W., Moul, Judd W., Ohlendorf, Brian, Laskowitz, Daniel T., Waligorska, Teresa, Shaw, Leslie M., Whitson, Heather E., Cohen, Harvey J., Mathew, Joseph P.
• Format: Article
• Language: English
• Subjects: Aged; Alzheimer's disease; Amyloid beta-Peptides - cerebrospinal fluid; Biomarkers; Biomarkers - cerebrospinal fluid; Cerebrospinal fluid; Cognition & reasoning; Datasets; Dementia; Female; Follow-Up Studies; General anesthesia; Humans; Male; Middle Aged; Neurodegeneration; Neurodegenerative Diseases - cerebrospinal fluid; Neurodegenerative Diseases - etiology; Neurodegenerative Diseases - physiopathology; Older people; Patients; Perioperative care; Postoperative Cognitive Complications - physiopathology; Postoperative Complications - cerebrospinal fluid; Preoperative Period; Standard deviation; Surgery; tau Proteins - cerebrospinal fluid
• ISSN: 2328-9503; 2328-9503
• DOI: 10.1002/acn3.51499

Objective Numerous investigators have theorized that postoperative changes in Alzheimer's disease neuropathology may underlie postoperative neurocognitive disorders. Thus, we determined the relationship between postoperative changes in cognition and cerebrospinal (CSF) tau, p‐tau‐181p, or Aβ levels after non‐cardiac, non‐neurologic surgery in older adults. Methods Participants underwent cognitive testing before and 6 weeks after surgery, and lumbar punctures before, 24 h after, and 6 weeks after surgery. Cognitive scores were combined via factor analysis into an overall cognitive index. In total, 110 patients returned for 6‐week postoperative testing and were included in the analysis. Results There was no significant change from before to 24 h or 6 weeks following surgery in CSF tau (median [median absolute deviation] change before to 24 h: 0.00 [4.36] pg/mL, p = 0.853; change before to 6 weeks: −1.21 [3.98] pg/mL, p = 0.827). There were also no significant changes in CSF p‐tau‐181p or Aβ over this period. There was no change in cognitive index (mean [95% CI] 0.040 [−0.018, 0.098], p = 0.175) from before to 6 weeks after surgery, although there were postoperative declines in verbal memory (−0.346 [−0.523, −0.170], p = 0.003) and improvements in executive function (0.394, [0.310, 0.479], p  0.05 for each). Interpretation Neurocognitive changes after non‐cardiac, non‐neurologic surgery in the majority of cognitively healthy, community‐dwelling older adults are unlikely to be related to postoperative changes in AD neuropathology (as assessed by CSF Aβ, tau or p‐tau‐181p levels or the p‐tau‐181p/Aβ or tau/Aβ ratios). Trial Registration: clinicaltrials.gov (NCT01993836).